期刊文献+

具有光学活性的葡萄糖酸尤利沙星制备及体外抗菌活性初步研究 被引量:3

Preparation of optically active isomers ulifloxacin glyconate and prelimilary study on antibiotic activity in vitro
暂未订购
导出
摘要 目的将消旋的尤利沙星进行手性拆分制备葡萄糖酸左旋尤利沙星和葡萄糖酸右旋尤利沙星,并对其抗菌活性进行初步比较研究。方法采用D-和L-酒石酸手性试剂,对消旋的尤利沙星进行手性拆分得到S和R构型的尤利沙星对映体,分别与葡萄糖酸反应,制备了葡萄糖酸左旋尤利沙星和葡萄糖酸右旋尤利沙星,选择4种菌株测定其体外抗菌活性。结果葡萄糖酸左旋尤利沙星的体外抗菌活性均明显强于葡萄糖酸右旋尤利沙星或消旋的尤利沙星。结论采用手性试剂对消旋的尤利沙星进行拆分的方法可行,葡萄糖酸左旋尤利沙星有进一步研发的价值。 Objective To prepare the optically acive isomers of S- and R- ulifloxacin glyconate, and study the prelimilary antibiotic activity of S- and R- ulifloxacin glyconate in vitro. Methods The S- or R- ulifloxacin was prepared by chiral resolution of racemic ulifloxacin with D- or L-tartaric acid, and then gone through the reactions between S- and R- ulifloxacin with the glucanic acid. The antibacterial effect of S- or R- ulifloxacin was determinded by four suitable bacterial strains in vitro. Results S- and R- ulifloxacin glyconate were successfully prepared respectively. The antibiotic activity of S-ulifloxacin was significantly higher than that of R-ulifloxacin in vitro. Conclusions It is practical to use the method of chiral resolution of racemic ulifloxacin with chiral reagent. The S-ulifloxacin has further-researching potency.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2008年第12期756-757,I0001,共3页 Chinese Journal of Antibiotics
基金 广州市科技局科技攻关计划项目(编号:2007Z3-E4091)
关键词 尤利沙星 抗菌活性 手性拆分 Ulifloxacin Antibiotic activity Chiral resolution
  • 相关文献

参考文献4

  • 1Ozaki M, Komori K, Matsuda M, et al. Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes[J]. Antimicrob Agents Chemother, 1996,40(3) : 739-742.
  • 2李敏,黄山,倪沛洲.新一代喹诺酮类药物NM394的合成[J].中国新药杂志,2005,14(1):67-69. 被引量:4
  • 3黄濑正博,北野正彦,尾崎正邦.光学活性キノリッカポソ酸诱导体[P].日本公开特许公报:平3-218383,1991-9-25.
  • 4程春生,张宝砚,李鹏,杨贺选.普卢利沙星的合成[J].中国医药工业杂志,2005,36(2):67-69. 被引量:23

二级参考文献16

  • 1方利明,金艳,魏敏吉.氟喹诺酮类抗菌剂——普卢利沙星[J].中国医药导刊,2004,6(3):225-227. 被引量:20
  • 2程春生,张宝砚,李鹏,杨贺选.6,7-二氟-4-羟基-2-甲氧甲硫基-3-喹啉羧酸乙酯的合成[J].中国医药工业杂志,2004,35(8):459-460. 被引量:5
  • 3王金生,宋慈媛.新氟喹诺酮抗菌药NM441[J].国外医药(抗生素分册),1996,17(3):224-226. 被引量:11
  • 4Hoshino K, Kitamura A, Morrissey I, et al. Comparison of inhibition of Escherichia coil topoisomerase Ⅳ by quinolones with DNA gyrase inhibition[J] .Antimicrob Agents Chemother,1994, 38(11) : 2623-2627.
  • 5Segawa J, Kitano M, Kazuno K, et al. Studies on pyridonecarboxylic acid. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo.4-oxo.4H- [1,3 ] thiazeto[3,2-a] quinoline-3-carboxylic acids [J]. J Med Chem, 1992,35 (25) : 4727-4738.
  • 6Kise M, Kitano M, Ozaki M, et al. Quinolinecarboxylic acid derivatives[P]. EP: 315828, 1989-05-17. (CA 1989, 111:194791n).
  • 7Itoh Y, Kato H, Koshinaka E, et al. Optically active thiazetoquinoline-3-carboxylic acid compound, method for preparation thereof and a pharmaceutical composition comprising the same[P]. EP: 465716, 1992-01-15; EP:393538, 1990-10-24. (CA 1991, 114: 143397t).
  • 8Friedrich EC, Falling SN, Lyons DE. A convenient synthesis of ethyldine iodide[J]. Synth Commun, 1975, 5 (1) : 33-36.
  • 9Sakamoto F, Ikeda S, Tsukamoto G. Studies on Prodrugs. Ⅱ.Preparation and characterization of (5-substituted 2-oxo-1,3-dioxolen-4-yl) esters of ampicillin [ J ]. Chem Pharm Bull, 1984,32(6) : 2241-2248.
  • 10Tracy M. Prulifloxacin[J].Drugs Future,1996,21(8):805- 810.

共引文献23

同被引文献16

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部